Livongo Health (LVGO) Stock Price, News & Analysis

Company Overview

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.

Key Stats

• Today's Range: $139.77 to $139.77
• 50-Day Range: $136.67 to $148.08
• 52-Week Range: $18.76 to $151.05
• Volume: N/A
• Average Volume: 3.04 million shs
• Market Capitalization: $14.20 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LVGO Stock Analysis - Frequently Asked Questions

How were Livongo Health's earnings last quarter?

Livongo Health, Inc. (NASDAQ:LVGO) announced its earnings results on Wednesday, October, 28th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.11. The business had revenue of $106.10 million for the quarter, compared to analysts' expectations of $95.57 million. Livongo Health had a positive trailing twelve-month return on equity of 0.29% and a negative net margin of 12.20%.

When did Livongo Health IPO?

Livongo Health (LVGO) raised $230 million in an initial public offering (IPO) on Thursday, July 25th 2019. The company issued 10,700,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan served as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers.

What other stocks do shareholders of Livongo Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Livongo Health investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Tesla (TSLA), Meta Platforms (META), PayPal (PYPL) and Salesforce (CRM).

Company Calendar

• Last Earnings: 10/28/2020
• Today: 3/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Computer Programming, Data Processing, & Other Computer Related
• Sub-Industry: N/A
• Current Symbol: NASDAQ:LVGO
• CIK: N/A
• Web: www.livongo.com
• Phone: 866-435-5643
• Fax: N/A
• Employees: 471
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-55,270,000.00
• Net Margins: -12.20%
• Pretax Margin: N/A
• Return on Equity: 0.29%
• Return on Assets: 0.21%

Debt

• Debt-to-Equity Ratio: 0.69
• Current Ratio: 19.88
• Quick Ratio: 19.51

Sales & Book Value

• Annual Sales: $170.20 million
• Price / Sales: 83.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $5.37 per share
• Price / Book: 26.03

Miscellaneous

• Outstanding Shares: 101,585,000
• Free Float: N/A
• Market Cap: $14.20 billion
• Optionable: Not Optionable
• Beta: 1.81